The risks associated with short-term placebo-controlled antihypertensive clinical trials: A descriptive meta-analysis

Journal of Human Hypertension

Volumn 22, Issue 10, 2008, Pages 659-668

  DeFelice, A ^a   Willard, J ^a   Lawrence, J ^a   Hung, J ^a   Gordon, M A ^a   Karkowsky, A ^a   Targum, S ^a   Throckmorton, D C ^a   Girton, J ^b   Stertz, B ^b   Glasser, S P ^c   Lipicky, R J ^d  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Ischemia Research and Education Foundation   (United States)

^c University of Alabama at Birmingham   (United States)

^d Lipicky LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENKEPHALINASE INHIBITOR; PLACEBO;

ABNORMAL LABORATORY RESULT; ANGIONEUROTIC EDEMA; ARTICLE; ASTHENIA; BLOOD PRESSURE REGULATION; BRADYCARDIA; CLINICAL TRIAL; DESCRIPTIVE RESEARCH; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG MARKETING; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAM; EVIDENCE BASED MEDICINE; FATIGUE; FOOD AND DRUG ADMINISTRATION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART INFARCTION; HEART PALPITATION; HUMAN; HYPERTENSION; HYPOTENSION; LEG EDEMA; LETHARGY; META ANALYSIS; MORTALITY; ORTHOSTATIC HYPOTENSION; RISK ASSESSMENT; SEXUAL DYSFUNCTION; SHORT COURSE THERAPY; SIDE EFFECT; STROKE; SYNCOPE; SYSTEMATIC REVIEW; THORAX PAIN; TREATMENT DURATION;

ANTIHYPERTENSIVE AGENTS; CONTROL GROUPS; CONTROLLED CLINICAL TRIALS AS TOPIC; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYPERTENSION; PATIENT DROPOUTS; PLACEBOS; RISK ASSESSMENT;

EID: 52749087967     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2008.51     Document Type: Article

References (36)

1. Collins R, Peto K, MacMahon S, Hebert P, Fiebach NH, Eberlein KA et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-838.
2. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994; 50: 272-298.
3. Thijs L, Fagard RH, Lijnen P, Staessen JA, van Hoof R, Amery A. A meta-analysis of outcome trials in elderly hypertensives. J Hypertens 1992; 10: 1103-1109.
4. Staessen JA, Gasowski J, Wang JG, Lutgarde T, Hond ED, Boissel J-P et al. Risk of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials. Lancet 2000; 355 865-872.
5. Wang JG, Staessen JA. Conventional therapy and newer drug classess for cardiovascular protection in hypertension. J Am Soc Nephrol 2002: 13(Suppl 3): S208-S215.
6. Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: A quantitative overview updated until 1 March 2003. J Hypertens 2003; 21: 1055-1076.
7. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials. Lancet 2003; 362: 1527-1535.
8. Chaudhry SI, Krumholz HM, Foody JM. Systolic hypertension in older persons. JAMA 2004; 292: 1074-1080.
9. White WB. Update on the drug treatment of hypertension in patients with cardiovascular disease. Am J Med 2005; 118: 695-705.
10. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman L, Ekman S et al Outcomes in hypertensive patients at high cardiovascular risk treated with regimes based on valsartan or amlodipine: The VALUE randomised trial. Lancet 2004; 363: 2022-2031.
11. Staessen JA, Thijs L, Fagard RH, Celis H, Birkenhäger WH, Bulpit CJ et al. Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe. Trial. J Hypertens 2004; 22: 847-857.
12. Al-Khatib SM, Califf RM, Hasselblad V, Alexander JH, McCrory DC, Sugarman J. Medicine. Placebo-controls in short-term clinical trials of hypertension. Science 2001; 292: 2013-2015.
13. Newcombe RG. Interval estimation for the difference between independent proportions: Comparison of eleven methods. Stat Med 1998: 17 873-890.
14. Hasselblad V, Mosteller F, Littenberg B, Chalmers TC, Hunink MG, Turner JA et al. A survey of current problems in meta-analysis. Discussion from the Agency for Health Care Policy and Research inter-PORT Work Group on Literature Review/Meta-Analysis. Med Care 1995; 33: 202-220.
15. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl Cancer Inst 1959; 22 719-748.
16. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 1985; 27: 335-371.
17. The Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970; 213: 1143-1152.
18. Helgeland A. Treatment of mild hypertension: A five year controlled drug trial. The Oslo Study. Am J Med 1980; 69: 725-732.
19. Report by the Management Committee. The Australian therapeutic trial in mild hypertension. Lancet 1980; 1: 1261-1267.
20. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: Principal results. BMJ (Clin Res Ed) 1985; 291 97-104.
21. Wang JG, Staessen JA, Gong L, Liu L. Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertensio in China (Syst-China) Collaborative Group. Arch Intern Med 2000; 160: 211-220.
22. Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ (Clin Res Ed) 1986; 293 1145-1151.
23. Staessen JA, Fagard RH, Thijs L, Celis H, Arabidze GG, Birkenhäger of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-764.
24. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991: 265: 3255-3264.
25. Amery A, Birkenhäger WH, Brixko P, Bulpitt C, Clement D, Derutterre M. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; 1: 1349-1354.
26. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: Principal results. BMJ 1992; 304 405-412.
27. Dahlöf B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-1285.
28. Bulpitt CJ, Beckett NS, Cooke J. Dumitrascu DL, Gil-Extremera B, Nachev C et al. Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens 2003; 21: 2409-2417.
29. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335 765-774.
30. Hoyert DL, Kung HC, Smith BL. Deaths: Preliminary data for 2003. Natl Vital Stat Rep 2005; 53: 1-48.
31. Rutledge J, Ayers C, Davidson R, DiPette D, Gordon G, Fisher M et al Effect of intravenous enalaprilat in moderate and severe systemic hypertension. Am J Cardiol 1988; 62: 1062-1067.
32. Habib GB, Dunbar LM, Rodrugues R, Neale AC, Friday KJ. Evaluation of the efficacy and safety of oral nicaradipine in the treatment of urgent hypertension: A multicenter, randomized, double-blind, parallel, placebo-controlled clinical trial. Am Heart J 1995; 129: 917-923.
33. Handler J. Hypertensive urgency. J Clin Hypertens (Greenwich) 2006; 8(1): 61-64.
34. Cherney D, Straus S. Management of patients with hypertenisve urgencies and emergencies. J Gen Intern Med 2002; 17: 927-945.
35. Glasser SP, Clark PI, Lipicky RJ, Olive ES, Hubbard JM, Yusuf S. Exposing patients with chronic, stable, exertional angina to placebo periods in drug trials. JAMA 1991; 265: 1150-1154.
36. DeFelice A, Gordon MA, Hung J, Karkowsky A, Lawrence J, Pelayo JC et al. Placebo in Hypertension Adverse Reaction Meta-analysis (PHARM). Circulation 2003; 108(17) (Suppl): IV-452.